J Dermatol. 2017 Sep;44(9):1020-1023. doi: 10.1111/1346-8138.13853. Epub 2017 Apr 25. Biologic treatments for elderly patients with psoriasis. Momose M(1)
The number of elderly patients with psoriasis is increasing in Japan. However, biologic treatment is generally considered to be challenging in elderly patients, .
Biological therapy has revolutionized moderate to severe psoriasis treatment.. .. that elderly patients represent a significant subset of patients with psoriasis.
included in this issue we look at biologic treatments for elderly patients,. mild psoriasis, the risk of malignancy with systemic psoriasis treatment, serious .
treatments such as cyclosporine, infliximab and ustekinumab). PsA Q1: In. .. Elderly. The use of biologic agents in elderly patients (65 years or older) is limited
Biologic agents that target TNF-Î±, IL-12/-23, and IL-17 inhibitors are highly. Management of elderly psoriasis patients with systemic medications may be .
Psoriatic arthritis, which affects 6 to 17% of patients with psoriasis according to. of and treatment patterns for psoriasis among the growing elderly population, which,. .. Factors associated with biologic use among patients receiving therapy
Appropriate treatment for elderly patients with limited psoriasis include the. methotrexate, and biologics as the first-line systemic treatments for patients with .